Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
The NetherlandsStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
The NetherlandsStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
The NetherlandsStudy on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors
The NetherlandsA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
The NetherlandsA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
The NetherlandsPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
The NetherlandsLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
The NetherlandsA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
The NetherlandsPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
The NetherlandsEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
The NetherlandsA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
